Carlyle $145 million acquisition of 37% of Metropolis Healthcare

Overview:

• Carlyle has acquired a 37% stake in Metropolis Healthcare for $145 million.
• Metropolis Healthcare is a leading multinational pathology lab testing business that operates in India, Sri Lanka, the Middle East and Africa.
• It undertakes over 15 million medical tests a year through 10,000 laboratories and hospitals.
• The stake was acquired from Dr GSK Velu and his affiliates.  
• Carlyle already has interests in the Indian healthcare sector having acquired a stake in Global Health.

Katrin Kostadinova - Data analyst